Abstract
Cardiovascular disease remains a significant cause of mortality and morbidity despite relentless ongoing research all over the world. The different cardiovascular societies and research organizations are in a constant effort to improve overall cardiovascular (CV) outcome by conducting trials and establishment of guidelines. The ever growing health care costs have enforced governmental agencies to develop quality performance measures which are addressed towards increasing quality, safety, efficiency of patient care and to curtail the cost of health care. Clinical registries are observational databases which provide detailed information about patient population, a specific disease or a clinical condition, therapy or procedure. These can be utilized in estimating appropriateness of health care delivery and providing feedback to providers and health care organizations for gauging their performance at regional and national level. The introduction of electronic health records (EHR) has immensely helped the workflow and maintenance of clinical registries with their integrated software.
Keywords: Clinical registries, electronic health records, health care costs, randomized control trials.
Graphical Abstract
Current Vascular Pharmacology
Title:Use of Chronic Disease Registries to Optimize Cardiovascular Health
Volume: 14 Issue: 5
Author(s): Sucheta Gosavi and Aparna Bhagavat
Affiliation:
Keywords: Clinical registries, electronic health records, health care costs, randomized control trials.
Abstract: Cardiovascular disease remains a significant cause of mortality and morbidity despite relentless ongoing research all over the world. The different cardiovascular societies and research organizations are in a constant effort to improve overall cardiovascular (CV) outcome by conducting trials and establishment of guidelines. The ever growing health care costs have enforced governmental agencies to develop quality performance measures which are addressed towards increasing quality, safety, efficiency of patient care and to curtail the cost of health care. Clinical registries are observational databases which provide detailed information about patient population, a specific disease or a clinical condition, therapy or procedure. These can be utilized in estimating appropriateness of health care delivery and providing feedback to providers and health care organizations for gauging their performance at regional and national level. The introduction of electronic health records (EHR) has immensely helped the workflow and maintenance of clinical registries with their integrated software.
Export Options
About this article
Cite this article as:
Gosavi Sucheta and Bhagavat Aparna, Use of Chronic Disease Registries to Optimize Cardiovascular Health, Current Vascular Pharmacology 2016; 14 (5) . https://dx.doi.org/10.2174/1570161114666160722114413
DOI https://dx.doi.org/10.2174/1570161114666160722114413 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natriuretic Peptide Guided Heart Failure Management
Current Clinical Pharmacology Epsilon Waves as an Extreme Form of Depolarization Delay: Focusing on the Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
Current Cardiology Reviews Renin Angiotensin System as a Regulator of Cell Volume. Implications to Myocardial Ischemia
Current Cardiology Reviews Understanding the Cardiovascular Actions of Soy Isoflavones: Potential Novel Targets for Antihypertensive Drug Development
Cardiovascular & Hematological Disorders-Drug Targets Effects of Mesenchymal Stromal Cells on Diabetic Cardiomyopathy
Current Pharmaceutical Design Crude Venom from Nematocysts of the Jellyfish Pelagia noctiluca as a Tool to Study Cell Physiology
Central Nervous System Agents in Medicinal Chemistry Peroxisome Proliferator-Activated Receptor (PPAR)β /δ: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome
Current Molecular Pharmacology Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
Current Organic Synthesis Animal Models Used for the Evaluation of Antiretroviral Therapies
Current HIV Research Management of Cardiogenic Shock due to Thyrotoxicosis: A Systematic Literature Review
Current Cardiology Reviews Adipose Triglyceride Lipase: A New Target in the Regulation of Lipolysis by Insulin
Current Diabetes Reviews Principles and Therapeutic Relevance for Targeting Mitochondria in Aging and Neurodegenerative Diseases
Current Pharmaceutical Design Heart Failure in East Asia
Current Cardiology Reviews Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly
Current Medicinal Chemistry Cardiac Mitochondrial Alterations Observed in Hyperglycaemic Rats - What Can We Learn From Cell Biology?
Current Diabetes Reviews Role of Oxidative Stress and Mitochondrial Dysfunction in Skeletal Muscle in Type 2 Diabetic Patients
Current Pharmaceutical Design Cord Blood as Diagnostic Window for Preeclampsia
Recent Patents on Biomarkers Can Wogonin be Used in Controlling Diabetic Cardiomyopathy?
Current Pharmaceutical Design Subject Index To Volume 2
Current Cardiology Reviews The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets